about
Core I gene is overexpressed in Hürthle and non-Hürthle cell microfollicular adenomas and follicular carcinomas of the thyroidSTAT3 negatively regulates thyroid tumorigenesisInvolvement of p53 in cell death following cell cycle arrest and mitotic catastrophe induced by rotenone.Mitochondrial dynamics protein Drp1 is overexpressed in oncocytic thyroid tumors and regulates cancer cell migrationHürthle (oncocytic) cell tumors of thyroid: etiopathogenesis, diagnosis and clinical significance.Somatic and germline mutation in GRIM-19, a dual function gene involved in mitochondrial metabolism and cell death, is linked to mitochondrion-rich (Hurthle cell) tumours of the thyroid.Molecular alterations and expression of succinate dehydrogenase complex in wild-type KIT/PDGFRA/BRAF gastrointestinal stromal tumors.Intragenic mutations in thyroid cancer.The biology and the genetics of Hurthle cell tumors of the thyroid.RET/PTC rearrangement is prevalent in follicular Hürthle cell carcinomas.Oncocytic lesions of the thyroid, kidney, salivary glands, adrenal cortex, and parathyroid glands.Mitochondria dynamism: of shape, transport and cell migration.Overexpression of pyruvate dehydrogenase kinase supports dichloroacetate as a candidate for cutaneous melanoma therapy.A glycolytic phenotype is associated with prostate cancer progression and aggressiveness: a role for monocarboxylate transporters as metabolic targets for therapy.The prognostic impact of TERT promoter mutations in glioblastomas is modified by the rs2853669 single nucleotide polymorphism.OXPHOS dysfunction regulates integrin-β1 modifications and enhances cell motility and migration.GLUT1, MCT1/4 and CD147 overexpression supports the metabolic reprogramming in papillary renal cell carcinoma.Etiopathogenesis of oncocytomas.Orthovanadate-induced cell death in RET/PTC1-harboring cancer cells involves the activation of caspases and altered signaling through PI3K/Akt/mTOR.Mitochondrial D310 D-Loop instability and histological subtypes in radiation-induced cutaneous basal cell carcinomas.Germline succinate dehydrogenase subunit D mutation segregating with familial non-RET C cell hyperplasia.GRIM-19 in Health and Disease.GRIM-19 mutations are not associated with Crohn's disease.Dynamin-Related Protein 1 at the Crossroads of Cancer.Synergistic growth inhibition of cancer cells harboring the RET/PTC1 oncogene by staurosporine and rotenone involves enhanced cell death.STAT3:FOXM1 and MCT1 drive uterine cervix carcinoma fitness to a lactate-rich microenvironment.Warthin's tumour.Helicobacter pylori infection induces genetic instability of nuclear and mitochondrial DNA in gastric cells.An assessment of the clonality of the components of canine mixed mammary tumours by mitochondrial DNA analysis.A new PKLR gene mutation in the R-type promoter region affects the gene transcription causing pyruvate kinase deficiencyAbsence of theBRAFand theGRIM-19Mutations in Oncocytic (Hürthle Cell) Solid Cell Nests of the ThyroidA novel germline SDHB mutation in a gastrointestinal stromal tumor patient without bona fide features of the Carney–Stratakis dyadMitochondrial D-Loop instability in thyroid tumours is not a marker of malignancyReply to: Low prevalence of BRAF mutations in radiation-induced thyroid tumors in contrast to sporadic papillary carcinomasType and prevalence of BRAF mutations are closely associated with papillary thyroid carcinoma histotype and patients’ age but not with tumour aggressivenessBRAF mutations are associated with some histological types of papillary thyroid carcinomaBRAF mutations and RET/PTC rearrangements are alternative events in the etiopathogenesis of PTCAbnormalities of the E-cadherin/catenin adhesion complex in classical papillary thyroid carcinoma and in its diffuse sclerosing variantMicrosatellite instability, mitochondrial DNA large deletions, and mitochondrial DNA mutations in gastric carcinomaComments on: Mutations in Mitochondrial Control Region DNA in Gastric Tumours of Japanese Patients, Tamura, et al. Eur J Cancer 1999, 35, 316–319
P50
Q24796416-9CFF4EA7-2267-4919-AF57-408725A12645Q28505424-B1F74ACE-3C85-4BEF-A291-145BCF0AC954Q34636091-D1378980-4DC5-4C7B-A325-AC11709ABD46Q35231712-5C5802E6-25A9-43AD-9D22-4BFAC6E8E809Q36056789-4D4C68B1-1420-40AC-9F8F-CFB0F3E35249Q36615843-D2CBF77C-BA36-4322-82B6-C7E9823CAD39Q36809668-5059D55E-9C60-484F-ABA6-991BC1ACA705Q37172760-BF4FD9B9-0871-4AEA-81B8-D38079A8BDA1Q38003587-63A704AA-76D5-4F51-A3BC-C9EBCD33ABD9Q38026893-46BF4E5F-3551-4EA5-83E7-6C403A4062AFQ38177111-23BC7D80-5D4E-48C7-A3D7-44A231498924Q38179990-82DE7449-8B22-4474-B878-4B065F2BCD0BQ38874710-8B1AE292-0C59-4D18-9260-01E9519B990DQ38886986-479AB33C-0564-4070-B1CE-BA04347E4FDFQ38903424-586C9919-9BFE-42C0-808C-063D0E5457C0Q38928748-521CA605-10AA-4E98-AB21-54423C47239BQ39061082-9183DEE9-256D-43E9-9591-78381A11455CQ39421661-77EEA4D7-1CEB-403B-8749-3EA5E41C0A06Q39496999-DBE4E284-3CA9-4D66-A339-0B15A6FBCAF3Q42445888-D7AA62AA-146B-4F46-92A7-23CB300C25F8Q44616534-D9F327F4-16B0-482B-9E69-CAD4C8F09174Q46834896-BA06EDBE-BD07-4272-808A-7E26990FC37EQ46893637-529940B1-675A-4B83-ADD9-B92F62470500Q52692095-190450EF-143E-4374-98D3-80B69DD501DCQ52726251-70454934-6484-40A0-8B38-73862D00F86AQ52902978-1EC60738-AC44-4665-98C5-38CAC61B53D9Q53347517-E7F87A25-B898-40AB-AE2F-C5F07DA3F074Q54485899-DD0B3DE7-762B-425F-A2F7-FC699A7D5DBBQ54518330-C34EC9D3-22CA-47EC-A963-764575D56D57Q59485035-9DBEE46A-3D9B-46A1-8E5E-920935120986Q60526751-F99AB321-8622-4A83-9A30-83DF6026ECBAQ60526951-F3DE4E70-DF2A-4298-92B2-C8F3583CAF6DQ60527129-954DD8DA-617A-419B-884B-BBD2DD18D537Q60527133-5A5391D8-0908-498D-831E-4D5454916EDFQ60527135-BBEB5AC3-5499-430B-86C2-BB907C052FA6Q60527136-FA35D7CF-9A13-4F98-85FB-D903D5BC066BQ60527142-824E81D0-E16C-45FB-9A1F-0731FAC5EA2CQ60527150-284C0C8D-6578-4591-845B-19E732BABCA8Q60527152-CDB21CAC-1FC3-42E6-9DB2-718A7D2A1585Q60527154-2DEEDEC9-413B-488D-AD6C-F8B2DD134692
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Valdemar Maximo
@ast
Valdemar Maximo
@en
Valdemar Maximo
@es
Valdemar Maximo
@nl
Valdemar Maximo
@sl
type
label
Valdemar Maximo
@ast
Valdemar Maximo
@en
Valdemar Maximo
@es
Valdemar Maximo
@nl
Valdemar Maximo
@sl
prefLabel
Valdemar Maximo
@ast
Valdemar Maximo
@en
Valdemar Maximo
@es
Valdemar Maximo
@nl
Valdemar Maximo
@sl
P1053
E-7480-2011
P106
P1153
6602739233
P21
P31
P3829
P496
0000-0002-8631-8356